ロード中...

Metabolomic Biomarkers for Detection, Prognosis and Identifying Recurrence in Endometrial Cancer

Metabolic reprogramming is increasingly recognised as one of the defining hallmarks of tumorigenesis. There is compelling evidence to suggest that endometrial cancer develops and progresses in the context of profound metabolic dysfunction. Whilst the incidence of endometrial cancer continues to rise...

詳細記述

保存先:
書誌詳細
出版年:Metabolites
主要な著者: Njoku, Kelechi, Sutton, Caroline J.J, Whetton, Anthony D., Crosbie, Emma J.
フォーマット: Artigo
言語:Inglês
出版事項: MDPI 2020
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7463916/
https://ncbi.nlm.nih.gov/pubmed/32751940
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/metabo10080314
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!